Symbol: |
SPTBN2
|
Description: |
spectrin, beta, non-erythrocytic 2 [Source:HGNC Symbol;Acc:11276]
|
Location: |
Chr11:66452719-66496697[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:129
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPTBN2 |
ANTINEOPLASTIC-376265 |
0.001 |
Down |
SPTBN2 |
NSC 408470 |
0.02 |
Down |
SPTBN2 |
Neocuproin |
0.034 |
Down |
SPTBN2 |
FCDR |
0.009 |
Up |
SPTBN2 |
Camptothecin ethylglycinate ester hydrochloride |
0.042 |
Up |
SPTBN2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.046 |
Down |
SPTBN2 |
Camptothecin hemisuccinate sodium salt |
0.034 |
Up |
SPTBN2 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.003 |
Up |
SPTBN2 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.001 |
Up |
SPTBN2 |
ANTINEOPLASTIC-625543 |
0.003 |
Down |
SPTBN2 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.047 |
Up |
SPTBN2 |
L-Lysine, N-[(methylamino)carbonyl]-N'-(phenylmethoxy- carbonyl)-, phenylmethyl ester |
0.013 |
Up |
SPTBN2 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.036 |
Up |
SPTBN2 |
Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- |
0.044 |
Up |
SPTBN2 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride |
0.044 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:11
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:52
Total:4 Current:1
[First] [Prev]  Next Last 
|